Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Not Applicable

Completed

• Conditions: Sarcoma; Solid Tumor Gastrointestinal; Lung
• Interventions: Other: SMS/MMS text messaging; Other: usual care

• Registration Number: NCT02833246
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-06-28
• Study First Submitted: 2016-07-12
• Study First Submitted QC: 2016-07-12
• Study First Posted: 2016-07-14
• Status Verified: 2018-11
• Primary Completion: 2018-11-14
• Study Completion: 2018-11-14
• Last Update Submitted: 2018-11-16
• Last Update Posted: 2018-11-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

• Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
• Starting a new treatment regimen that includes a single oral anticancer medication
• Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
• Age 18 or older.
• Ability to speak and read English because we do not have the resources to translate the text messages into other languages.

Read More

Exclusion Criteria

• Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
SMS/MMS text messaging	SMS/MMS text messaging	Patients will be able to tailor their SMS/MMS reminders with respect to when (i.e., what time of day) they wish to receive the reminders, as well as how often the messages are sent (e.g., morning and evening).
usual care	usual care	This includes physician and nursing assessment and intervention for any identified AEs. Of note, there is not currently standard follow-up that patients receive from nursing or physician staff while on an OAM treatment. Patients are encouraged to call their physician's office with any questions or changes in their medical status but are not called routinely by MSK staff.

Primary Outcome Measures

Name	Time	Method
objective pill count	1 year	is greater or less than the amount of OAM that the patient should have in their possession.

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States